Optimisation of drug therapy in critical care

CRE REDUCE is pleased to present a full-day education opportunity following the Australian and New Zealand Intensive Care Society meeting in Sydney on 30 April 2022. 

The team led by Professor Jason Roberts, Professor Jeffrey Lipman and Dr Suzanne Parker will deliver education on the following topics:

  • Pharmacokinetics in critically ill patients
  • Microbiology and pathogen susceptibility considerations in ICU
  • Augmented Renal Clearance
  • Renal Replacement Therapy and Extracorporeal Membrane Oxygenation
  • Prolonged infusion of beta-lactams
  • Therapeutic drug monitoring in critically ill patients
  • Use of dosing software to optimise drug dosing
  • Optimised anti-convulsant dosing in critically ill patients
  • Optimised sedative dosing in critically ill patients

Optimisation of drug therapy in critical care

Sat 30 Apr 2022 9:00am4:30pm

The CRE REDUCE team includes some of Australia’s leading researchers on optimised drug therapy in critically ill patients, having published extensively in the areas of intensive care medicine, pharmacometrics and infectious diseases. CRE REDUCE and the Antimicrobial Optimisation Team at the UQ Centre for Clinical Research alongside their collaborators have delivered educational events for physicians, medical and allied health professionals around the globe. Some of these events include masterclasses on optimising antimicrobial therapy for serious infections in the intensive care environment, patients receiving extracorporeal support, and facilitated by therapeutic drug monitoring and dosing software, as well as workshops in pharmacometric modelling.

The education events are supported by industry through the sponsorships of CHU Nimes and Pfizer. Join CRE REDUCE for this unique educational opportunity.

Download the flyer here.

Payment through the ANZIC Society website.
Cost: $500 per physician and industry; $250 per Allied health participant